D

Pangenomic Health Inc. NARA

CNSX
Recommendation
Dividend Power Score
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Pangenomic Health Inc. is a Canadian health technology and wellness company focused on personalized health, genomics-informed consumer products, and digital health solutions. The company has operated in sectors that include consumer wellness, nutraceuticals, mental wellness support, and health data analytics. Public disclosures indicate that its strategy has centered on combining genomic insights, digital platforms, and consumer wellness products to support individualized health recommendations and preventative care initiatives.

The company’s reported business activities have included the development and commercialization of wellness products, digital health applications, and data-driven consumer engagement platforms. Revenue generation has historically been tied to product sales, technology-enabled wellness services, and acquisitions intended to expand its consumer health ecosystem. Publicly available information indicates that Pangenomic Health evolved through a combination of internal platform development and strategic acquisitions within the wellness and health technology sectors. Some operational and financial details remain limited in public reporting, and certain historical disclosures are not consistently detailed across available sources. Data inconclusive based on available public sources.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Monday, August 31, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Beginning of December (est)

Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
604-218-5788
Address
200 – 1575 W. Georgia St.
Vancouver, BC V6G 2V3
Country
Year Founded

Headlines

There are no news to display.